Army sbir PH II A2-6328, topic A15-061, award to roccor, LLC proposal title: "supersaturated oxygen emulsion for topical treatment of ocular trauma"
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH17C0008
- Awardee
-
Coruna Medical Inc. UEI JWDAJJYZRG53
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $975,680
Award facts
- Opportunity
-
- HQ003416R2ASB Solicitation number
- Contract value 100% obligated
- $975,680.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 6 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Longmont, CO 80503, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Novation Agreement | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $468,884 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $506,796 |
About this award
This $975,680.21 prime contract was awarded by the Department of the Army Medical Command to ROCCOR, LLC, a small business, under the Small Business Innovation Research (SBIR) program. The contract is for the development of a "supersaturated oxygen emulsion for topical treatment of ocular trauma."
The prime contractor, ROCCOR, LLC, has subcontracted work to the Schepens Eye Research Institute, a non-profit research organization, and the University of Colorado-Denver, a public research university, to support research and development activities. This includes evaluating the efficacy of the supersaturated oxygen emulsion in a mouse model of corneal injury, as well as overseeing the production of emulsion solutions for clinical trials. An additional subcontractor, Oxygen Emulsion Co, LLC, is providing manufacturing support.
The contract has a set-aside designation for total small business participation. It is part of the Army's SBIR program, which funds research and development of innovative technologies to address military needs.
Quick answers
Who was awarded contract W81XWH17C0008?
W81XWH17C0008 was awarded to Coruna Medical Inc. by Medical Command (Department of the Army) on May 15, 2017.
How much is contract W81XWH17C0008 worth?
The government has obligated $975,680 on W81XWH17C0008.
Was contract W81XWH17C0008 competed?
The extent of competition for W81XWH17C0008 was full and open competition after exclusion of sources. The government received 6 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award